Verification of the efficacy of test foods intake in VDT work in healthy adults.

Verification of the efficacy of the foods intake in VDT work in healthy adults. - A randomized, double-blind, placebo-controlled, crossover study- - Verification of the efficacy of the foods intake in VDT work in healthy adults.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054264

Enrollment

Registered

2024-04-26

Start date

2024-05-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

A single administration of the test food is performed. After a washout period, a single administration of placebo is performed. A single administration of the placebo is performed. After a washout per

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. healthy men and women between the ages of 18 and 65 at the time of obtaining written consent 2. people who perform VDT work on a daily basis

Exclusion criteria

Exclusion criteria: a. taking medication or under medical treatment b. pregnant, lactating, or intending to become pregnant during the study period c. Minors (under 18 years of age) d. under exercise therapy or dietetic therapy e. allergic to test food f. current dependence or history of either medicine or alcohol dependence syndrome g. current or prior diagnosis of mental illness (depression) or sleep disturbance h. extremely irregular lifestyle i. on a night-shift or shift worker j. unbalanced diet k. current disease or history of brain disease, malignant tumor, immunological disease, diabetes, renal disease, cardiac disease, thyroid disease, adrenal disease, or other metabolic disease. l. use of health foods, supplements, and medicines m. participation in other clinical studies within the past 3 months from the day of consent or planning to participate in other clinical studies during the current study; n. considered as an inappropriate candidate by the doctor in charge.

Design outcomes

Primary

Measure	Time frame
subjective evaluation(POMS2,VAS)	—

Secondary

Measure	Time frame
EEG, scores associated with VDT tasks	—

Countries

Japan

Contacts

Public ContactYusuke Yamashita

Pharma Foods International Co., Ltd. Research and Development

y-yamashita@pharmafoods.co.jp075-748-9829

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026